sync
BIST 10010,245.40trending_up+1.25%
Dolar / TL32.2440trending_down-0.12%
Euro / TL34.9810trending_up+0.05%
Altın (Ons)$2,342.50trending_down-0.38%
Bitcoin$68,420.00trending_up+3.15%
Brent Petrol$81.45trending_up+0.85%
BIST 10010,245.40trending_up+1.25%
Dolar / TL32.2440trending_down-0.12%
Euro / TL34.9810trending_up+0.05%
Altın (Ons)$2,342.50trending_down-0.38%
Bitcoin$68,420.00trending_up+3.15%
Brent Petrol$81.45trending_up+0.85%
BIST 10010,245.40trending_up+1.25%
Dolar / TL32.2440trending_down-0.12%
Euro / TL34.9810trending_up+0.05%
Altın (Ons)$2,342.50trending_down-0.38%
Bitcoin$68,420.00trending_up+3.15%
Brent Petrol$81.45trending_up+0.85%
Explainers

MedPAC Experts Unveil Critical Medicare Findings at National Research Summits

MedPAC researchers shared pivotal findings on Medicare Advantage, Part D, and provider networks at the 2026 AcademyHealth and ASHEcon national conferences.

MedPAC Experts Unveil Critical Medicare Findings at National Research Summits

MedPAC Engages the National Research Community

During the early weeks of this month, representatives from the Medicare Payment Advisory Commission (MedPAC) traveled to Seattle, Washington, and Minneapolis, Minnesota, to share vital findings with the healthcare policy community. By participating in the AcademyHealth Annual Research Meeting and the American Society of Health Economists (ASHEcon) Annual Conference, MedPAC experts ensured that their latest research remains accessible, transparent, and grounded in the broader scientific landscape. These presentations highlight the Commission’s commitment to keeping policymakers and the public informed about the evolving realities of the Medicare program.

MedPAC Experts Unveil Critical Medicare Findings at National Research Summits detayları
Fotoğraf: MedPAC Experts Unveil Critical Medicare Findings at National Research Summits detayları

Insights from the AcademyHealth Annual Research Meeting

Six MedPAC analysts took the stage in Seattle to present data that has shaped recent Congressional reports and public meetings. These presentations focused heavily on the shifting dynamics of Part D and Medicare Advantage (MA):

MedPAC Experts Unveil Critical Medicare Findings at National Research Summits gelişmeleri
Fotoğraf: MedPAC Experts Unveil Critical Medicare Findings at National Research Summits gelişmeleri
  • Betty Fout detailed the drivers behind recent Part D bid fluctuations following the Inflation Reduction Act of 2022.
  • Andy Johnson examined the impact of the V28 risk model on coding intensity within Medicare Advantage during its inaugural year.
  • Grace Oh investigated the pricing and cost-sharing structures for dialysis services within MA plans between 2018 and 2022.
  • Pamina Mejia provided a critical look at the accuracy of drug pricing data currently displayed on the Medicare Plan Finder tool.
  • Katelyn Smalley mapped mid-year volatility within Medicare Advantage provider networks during 2023.
  • Ledia Tabor offered comprehensive data on how beneficiaries navigate coverage choices and their overall understanding of the Medicare program from 2019 to 2023.

All these findings correspond with public discussions held during MedPAC’s January, March, and June 2026 meetings, as well as official reports submitted to Congress.

Advancements in Health Economics at ASHEcon

In Minneapolis, two additional analysts showcased research regarding the structural health of Medicare networks. Krista Cherry presented findings on provider participation trends in Medicare Advantage networks throughout 2023, a topic that underwent rigorous review during the Commission’s March 2026 public meeting. Concurrently, Renuka Diwan explored the intricacies of pharmacy access and preferred networks within the Part D landscape, building upon data reviewed during the April 2026 public meeting. These contributions solidify MedPAC’s role in providing data-driven perspectives on the complex economic factors governing modern healthcare delivery.

Recent Developments

MedPAC continues to provide breaking news regarding the fiscal and operational health of the Medicare program through its ongoing research initiatives. These latest updates, shared at national conferences, offer live news perspectives on how policy changes, such as the Inflation Reduction Act, impact beneficiary care and provider networks. You can follow all developments instantly on MedicareTicker.com.

Related Topics

🔹 Medicare Advantage 🔹 Part D Prescription Drugs 🔹 Healthcare Policy 🔹 Provider Networks 🔹 Inflation Reduction Act 🔹 MedPAC Research 🔹 Medicare Beneficiary Experience

Explainers News

This category covers essential background information and expert insights on the American healthcare system, focusing on regulatory shifts and fiscal policy. MedicareTicker.com provides breaking news and deep-dive explainers to ensure you stay informed with the latest updates, keeping you live with the most important changes in federal health programs.

Frequently Asked Questions

What was the purpose of MedPAC's participation in these conferences?

MedPAC staff attended these events to engage with the wider research community and ensure transparency regarding the Commission's recent findings. By presenting their work, they facilitate public and academic access to critical data concerning Medicare policy.

Which specific Medicare areas did the researchers focus on?

The presentations covered a wide range of topics, including Medicare Advantage coding intensity, Part D drug pricing accuracy, dialysis coverage, and the stability of provider networks. These subjects are central to the Commission's ongoing reporting to Congress.

How can the public access the research presented at these meetings?

All abstracts, posters, and presentation slides are available for public viewing on the official MedPAC website. This aligns with the Commission's mandate to maintain transparency in its advisory work.

AI Digest • Yapay Zeka Özeti

15 Saniyede Tek Bakışta Ne Oldu?

MedPAC researchers presented key findings on Medicare Advantage and Part D policies at the 2026 AcademyHealth and ASHEcon conferences. These presentations, which align with recent Congressional reports, offer data-driven insights into provider networks, drug pricing, and beneficiary experiences.